Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 1526

BillFederalHouseIn Committee
Reducing Hereditary Cancer Act
About This Bill
Committee
Latest Action · December 17, 2024
Referred to the Subcommittee on Health.
Congress
118th (2023–2025)
Introduced
March 9, 2023
Cosponsors (71)
59D 12R
View PDF ↗

Summary

Highlight any text to annotate
Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.